Sethi K D
Medical College of Georgia, Augusta, USA.
Semin Neurol. 2001;21(1):59-68. doi: 10.1055/s-2001-13120.
Movement disorders are frequently due to dopamine blocking agents (DBAs) prescribed for psychiatric illnesses. DBAs are sometimes also prescribed inappropriately for other maladies. These drugs can cause a wide variety of involuntary movements, sometimes in combination. When these appear in the setting of psychiatric illnesses, the association is easy to recognize but the treatment remains a difficult problem. However, in other situations the diagnosis may be missed for extended periods of time, resulting in unnecessary diagnostic work-up and inappropriate therapy. The diagnosis depends on a compulsive drug history not only from the patient but also from patient's family, primary physician, and the pharmacist. The treatment options include removal of the offending agent or substitution with an atypical neuroleptic. Symptomatic treatments are varied and have an inconsistent effect on the movement disorders. Prevention remains the most important strategy.
运动障碍常常是由用于治疗精神疾病的多巴胺阻断剂(DBA)引起的。DBA有时也被不恰当地用于治疗其他疾病。这些药物可导致各种各样的不自主运动,有时是多种运动同时出现。当这些症状出现在精神疾病患者身上时,这种关联很容易识别,但治疗仍然是一个难题。然而,在其他情况下,诊断可能会被长时间漏诊,从而导致不必要的诊断检查和不恰当的治疗。诊断不仅取决于患者本人,还取决于患者家属、初级医生和药剂师提供的详尽用药史。治疗选择包括停用致病药物或换用非典型抗精神病药物。对症治疗方法多样,对运动障碍的疗效不一。预防仍然是最重要的策略。